Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 5/20 | 0.58 |
| ▸ | REN | P00797 | 7/20 | 0.50 |
| ▸ | PLK3 | Q9H4B4 | 3/20 | 0.47 |
| ▸ | PLK2 | Q9NYY3 | 3/20 | 0.47 |
| ▸ | RAMP3 | O60896 | 6/20 | 0.45 |
| ▸ | CALCR | P30988 | 6/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16118965 | 0.95 | PLK1 (0.53) | PLK1RENRAMP3CALCR | |
| SCHEMBL13470572 | 0.94 | PLK1 (0.60) | PLK1RENPLK3PLK2RAMP3 | |
| SCHEMBL15729140 | 0.94 | PLK1 (0.60) | PLK1RENPLK3PLK2RAMP3 | |
| SCHEMBL17518879 | 0.94 | PLK1 (0.60) | PLK1RENPLK3PLK2RAMP3 | |
| SCHEMBL15729376 | 0.94 | PLK1 (0.61) | PLK1RENPLK3PLK2RAMP3 | |
| SCHEMBL20920260 | 0.93 | PLK1 (0.58) | PLK1RENPLK3PLK2 | |
| SCHEMBL13470171 | 0.92 | PLK1 (0.59) | PLK1RENPLK3PLK2 | |
| SCHEMBL20920239 | 0.91 | PLK1 (0.62) | PLK1RENPLK3PLK2 | |
| SCHEMBL17518828 | 0.90 | PLK1 (0.55) | PLK1RENPLK3PLK2RAMP3 | |
| SCHEMBL15729169 | 0.90 | PLK1 (0.56) | PLK1RENPLK3PLK2RAMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014153101-A2 | PEPTIDE AND PEPTIDE MIMETIC BINDING ANTAGONISTS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2014-09-25 | — | — | WO | disclosed |